公开(公告)号：US08808364B2

公开(公告)日：2014-08-19

申请号：US13240792

申请日：2011-09-22

申请人： Maria Palasis ,  Timothy J. Mickley ,  Toby Freyman ,  Wendy Naimark

发明人： Maria Palasis ,  Timothy J. Mickley ,  Toby Freyman ,  Wendy Naimark

IPC分类号： A61F2/06 ,  A61M29/00

CPC分类号： A61M31/002 ,  A61F2/24 ,  A61F2250/0067

摘要： The present invention relates to implantable medical devices and methods that employ these medical devices to treat heart valves. In one embodiment, a medical device is provided comprising a body. The body may have a portion thereof including therapeutic agent and can be configured to support the device proximate a heart valve. Methods in accordance with embodiments of the present invention may also include providing a medical device having a body with at least a portion thereof including a therapeutic agent. These methods may also include positioning the medical device in a location proximate to a downstream surface of the heart valve and securing the device. The therapeutic agent released may then be delivered to the heart valve.

摘要翻译： 本发明涉及使用这些医疗装置来治疗心脏瓣膜的可植入医疗装置和方法。 在一个实施例中，提供了包括身体的医疗装置。 身体可以具有其一部分，包括治疗剂，并且可被构造成在靠近心脏瓣膜的位置支撑装置。 根据本发明的实施例的方法还可以包括提供具有身体的医疗装置，其中至少一部分包括治疗剂。 这些方法还可以包括将医疗装置定位在靠近心脏瓣膜的下游表面的位置并固定装置。 然后释放的治疗剂可以被递送到心脏瓣膜。

公开(公告)号：US07892205B2

公开(公告)日：2011-02-22

申请号：US10455298

申请日：2003-06-06

申请人： Maria Palasis ,  Wendy Naimark ,  Toby Freyman ,  Samuel Epstein

发明人： Maria Palasis ,  Wendy Naimark ,  Toby Freyman ,  Samuel Epstein

IPC分类号： A61M37/00

CPC分类号： A61M11/06 ,  A61M25/0054 ,  A61M2025/0057

摘要： The present invention provides a catheter and catheter assembly for delivering micronized therapeutic agents to a target site in the body and, in particular, to a target site in the heart. The micronized therapeutic agents are delivered in aerosol form or dry powder form. The present invention also provides a method of delivering micronized therapeutic agents to a target site in the body by placing the therapeutic agents in a catheter, positioning the catheter in the target site, and exposing the therapeutic agents to an energizing mechanism sufficient to create supersonic flow to carry the therapeutic agents from a stationary state in the catheter to a mobile state towards the target site.

摘要翻译： 本发明提供一种导管和导管组件，用于将微粉化的治疗剂递送到身体中的靶部位，特别是向心脏中的靶位点递送。 微粉化治疗剂以气溶胶形式或干粉形式递送。 本发明还提供了一种通过将治疗剂放置在导管中将微粉化治疗剂递送到体内的靶位点的方法，将导管定位在靶位点，并将治疗剂暴露于足以产生超音速流动的激励机制 将治疗剂从导管中的静止状态运送到朝向目标部位的移动状态。

公开(公告)号：US07517338B2

公开(公告)日：2009-04-14

申请号：US11038241

申请日：2005-01-21

申请人： Toby Freyman ,  Maria Palasis ,  Wendy Naimark ,  William J. Shaw

发明人： Toby Freyman ,  Maria Palasis ,  Wendy Naimark ,  William J. Shaw

IPC分类号： A61M25/00 ,  A61M29/00

CPC分类号： A61M25/0068 ,  A61B2017/00247 ,  A61B2018/00392 ,  A61M25/0071 ,  A61M25/0074 ,  A61M25/0084 ,  A61M25/10 ,  A61M2025/0058 ,  A61M2025/0076 ,  A61M2025/0079 ,  A61M2025/0085 ,  A61M2025/0681

摘要： Embodiments of the present invention regard the delivery of therapeutic. One such apparatus may comprise multiple, independently-activated, injection devices for the delivery of therapeutic or other substances. This apparatus may include a first catheter; a second catheter in the first catheter and a multiple delivery member injection device. This multiple delivery member may include an expandable member and a plurality of injection elements. A third catheter may be positioned in the second catheter. This third catheter may have a distal end connected to a wall of the expandable member and a plurality of filling tubes connected to an distal end of the third catheter. In some of the embodiments each of the injection elements may hold a pressurized therapeutic prior to release of the therapeutic.

摘要翻译： 本发明的实施方案涉及治疗的递送。 一种这样的装置可以包括用于递送治疗剂或其它物质的多个独立激活的注射装置。 该装置可以包括第一导管; 第一导管中的第二导管和多个递送部件注射装置。 该多个传送构件可以包括可扩张构件和多个注射元件。 第三导管可以定位在第二导管中。 该第三导管可以具有连接到可扩张构件的壁的远端和连接到第三导管的远端的多个填充管。 在一些实施方案中，每个注射元件可以在释放治疗剂之前保持加压治疗。

公开(公告)号：US20070065414A1

公开(公告)日：2007-03-22

申请号：US11227278

申请日：2005-09-16

申请人： Toby Freyman ,  Maria Palasis ,  Wendy Naimark

发明人： Toby Freyman ,  Maria Palasis ,  Wendy Naimark

IPC分类号： A61K35/14 ,  C12N5/08 ,  A61K38/20

CPC分类号： A61M25/10 ,  A61K31/28 ,  A61K31/7076 ,  A61K35/28 ,  A61K45/00 ,  A61K45/06 ,  A61K2300/00 ,  A61M5/1407 ,  A61M2025/1052 ,  A61M2210/125

摘要： The present invention provides a method comprising administering cells by infusion through a blood vessel and administering a vasodilator, a vascular enhancer, or both. In accordance with one embodiment, the delivery of stem cells to the myocardium by intracoronary infusion is improved by administration of one or more vasodilators and/or vascular permeability enhancers prior to or at the time of cell therapy.

摘要翻译： 本发明提供了一种方法，其包括通过血管输注施用细胞并施用血管扩张剂，血管增强剂或两者。 根据一个实施方案，通过在细胞治疗之前或期间通过施用一种或多种血管扩张剂和/或血管通透性增强剂来改善通过冠状动脉内输注将干细胞递送至心肌。

公开(公告)号：US20060195059A1

公开(公告)日：2006-08-31

申请号：US11038241

申请日：2005-01-21

申请人： Toby Freyman ,  Maria Palasis ,  Wendy Naimark ,  William Shaw

发明人： Toby Freyman ,  Maria Palasis ,  Wendy Naimark ,  William Shaw

IPC分类号： A61M29/00

CPC分类号： A61M25/0068 ,  A61B2017/00247 ,  A61B2018/00392 ,  A61M25/0071 ,  A61M25/0074 ,  A61M25/0084 ,  A61M25/10 ,  A61M2025/0058 ,  A61M2025/0076 ,  A61M2025/0079 ,  A61M2025/0085 ,  A61M2025/0681

摘要： Embodiments of the present invention regard the delivery of therapeutic. One such apparatus may comprise multiple, independently-activated, injection devices for the delivery of therapeutic or other substances. This apparatus may include a first catheter; a second catheter in the first catheter and a multiple delivery member injection device. This multiple delivery member may include an expandable member and a plurality of injection elements. A third catheter may be positioned in the second catheter. This third catheter may have a distal end connected to a wall of the expandable member and a plurality of filling tubes connected to an distal end of the third catheter. In some of the embodiments each of the injection elements may hold a pressurized therapeutic prior to release of the therapeutic.

公开(公告)号：US20060029720A1

公开(公告)日：2006-02-09

申请号：US10909408

申请日：2004-08-03

申请人： Anastasia Panos ,  Wendy Naimark ,  Maria Palasis ,  Toby Freyman ,  Samuel Epstein

发明人： Anastasia Panos ,  Wendy Naimark ,  Maria Palasis ,  Toby Freyman ,  Samuel Epstein

IPC分类号： A61L33/00 ,  B05C5/00

CPC分类号： B05C5/0208 ,  A61F2/86 ,  A61F2002/072 ,  A61L31/08 ,  A61L31/10 ,  A61L2420/02 ,  B05C13/025 ,  B05D1/002 ,  B05D1/26 ,  B05D1/30

摘要： Methods and apparatus for coating at least a portion of the surface of medical devices using an injection coating device are disclosed. In one embodiment, the invention includes a coating method wherein an orifice of the injection coating device is placed adjacent a vertically positioned medical device, coating material is ejected from the orifice onto the medical device, and the coating material gravitationally flows downward coating the medical device. In another embodiment, an orifice of an injection coating device is positioned adjacent a horizontally positioned medical device to gravitationally flow and deposit coating material onto the medical device. These methods may be used to apply one or more coating materials, simultaneously or in sequence. In another embodiment, multiple injection coating devices may be utilized. In certain embodiments of the invention, the coating materials include therapeutic or biologically active agents.

摘要翻译： 公开了使用注射涂覆装置涂覆医疗装置的表面的至少一部分的方法和装置。 在一个实施方案中，本发明包括一种涂覆方法，其中注射涂覆装置的孔口邻近垂直定位的医疗装置放置，涂层材料从孔口喷射到医疗装置上，并且涂覆材料重力地向下流动涂覆医疗装置 。 在另一个实施例中，注射涂覆装置的孔口邻近水平定位的医疗装置定位以重力地流动并将涂层材料沉积到医疗装置上。 这些方法可以同时或按顺序施用一种或多种涂料。 在另一个实施例中，可以使用多个注射涂覆装置。 在本发明的某些实施方案中，涂层材料包括治疗或生物活性剂。

公开(公告)号：US20050181016A1

公开(公告)日：2005-08-18

申请号：US11076328

申请日：2005-03-10

申请人： Toby Freyman ,  Wendy Naimark ,  Maria Palasis

发明人： Toby Freyman ,  Wendy Naimark ,  Maria Palasis

IPC分类号： A61K35/12 ,  A61L27/36 ,  C12N5/071 ,  A61B17/58

CPC分类号： A61L27/3683 ,  A61K35/12 ,  A61L27/3633 ,  A61L2430/40 ,  C12N5/0679 ,  C12N2510/00

摘要： The invention is directed to an apparatus, such as a medical device, having a surface coated or covered with a decellularized extracellular matrix or having a component comprising the decellularized extracellular matrix for implantation into a subject, preferably a human. In one embodiment of the invention, a decellularized extracellular matrix is used to form a bodily implant such as a vein, an artery, an esophagus, or a ventricular restraining device. In some embodiments of the invention, the decellularized extracellular matrix is configured to be a time released therapeutic. In another embodiment of the invention, a decellularized extracellular matrix forms an aneurysm treatment device, such as an aneurysm coil, a seal, a pouch, or a filler. In a further embodiment of the invention, decellularized extracellular matrix is used to embolize lesions, tumors, or vessels. Methods for making the tissue regeneration scaffold and methods for manufacturing a coated or covered medical device having a component comprising decellularized extracellular matrix of body tissues are also provided.

摘要翻译： 本发明涉及一种诸如医疗装置的装置，其具有被脱细胞的细胞外基质包被或覆盖的表面，或具有包含用于植入受试者，优选人的脱细胞的细胞外基质的组分。 在本发明的一个实施方案中，使用脱细胞的细胞外基质形成诸如静脉，动脉，食管或心室抑制装置的身体植入物。 在本发明的一些实施方案中，脱细胞的细胞外基质被配置为时间释放的治疗剂。 在本发明的另一个实施方案中，脱细胞的细胞外基质形成动脉瘤治疗装置，例如动脉瘤线圈，密封件，小袋或填充物。 在本发明的另一个实施方案中，脱细胞的细胞外基质用于栓塞病变，肿瘤或血管。 还提供了用于制备组织再生支架的方法和用于制造具有包含身体组织的脱细胞的细胞外基质的组分的涂覆或覆盖的医疗装置的方法。

公开(公告)号：US20110130715A1

公开(公告)日：2011-06-02

申请号：US13022217

申请日：2011-02-07

申请人： Maria Palasis ,  Wendy Naimark ,  Toby Freyman ,  Samuel Epstein

发明人： Maria Palasis ,  Wendy Naimark ,  Toby Freyman ,  Samuel Epstein

IPC分类号： A61M5/00

CPC分类号： A61M11/06 ,  A61M25/0054 ,  A61M2025/0057

摘要： The present invention provides a catheter and catheter assembly for delivering micronized therapeutic agents to a target site in the body and, in particular, to a target site in the heart. The micronized therapeutic agents are delivered in aerosol form or dry powder form. The present invention also provides a method of delivering micronized therapeutic agents to a target site in the body by placing the therapeutic agents in a catheter, positioning the catheter in the target site, and exposing the therapeutic agents to an energizing mechanism sufficient to create supersonic flow to carry the therapeutic agents from a stationary state in the catheter to a mobile state towards the target site.

摘要翻译： 本发明提供一种导管和导管组件，用于将微粉化的治疗剂递送到身体中的靶部位，特别是向心脏中的靶位点递送。 微粉化治疗剂以气溶胶形式或干粉形式递送。 本发明还提供了一种通过将治疗剂放置在导管中将微粉化治疗剂递送到体内的靶位点的方法，将导管定位在靶位点，并将治疗剂暴露于足以产生超音速流动的激励机制 将治疗剂从导管中的静止状态运送到朝向目标部位的移动状态。

公开(公告)号：US20080085294A1

公开(公告)日：2008-04-10

申请号：US11538683

申请日：2006-10-04

申请人： Toby Freyman ,  Robert Herrmann ,  Wendy Naimark ,  Maria Palasis

发明人： Toby Freyman ,  Robert Herrmann ,  Wendy Naimark ,  Maria Palasis

IPC分类号： A61F2/00

CPC分类号： A61L31/16 ,  A61L31/148 ,  A61L2300/604

摘要： This invention comprises an apparatus for treating an atherosclerotic plaque in a coronary artery of a mammal by placing at or proximate to an entrance to the coronary artery and upstream of the vulnerable plaque, and an effective amount of a therapeutic agent for the treatment of the plaque. This invention comprises delivering a deposition of a therapeutic drug high in the coronary arterial tree for treatment of downstream vulnerable plaques. The invention also comprises slow release formulation and delivery of an apparatus that is totally degradable or removed and/or replaced.

摘要翻译： 本发明包括一种用于通过放置在冠状动脉入口处或接近于冠状动脉入口处和易损斑块上游来治疗哺乳动物冠状动脉中的动脉粥样硬化斑块的装置，以及有效量的用于治疗斑块的治疗剂 。 本发明包括在冠状动脉树中输送高度治疗药物的沉积物以治疗下游脆弱斑块。 本发明还包括缓释制剂和递送完全可降解或除去和/或更换的装置。

公开(公告)号：US20070178137A1

公开(公告)日：2007-08-02

申请号：US11344156

申请日：2006-02-01

申请人： Toby Freyman ,  Wendy Naimark ,  Maria Palasis

发明人： Toby Freyman ,  Wendy Naimark ,  Maria Palasis

IPC分类号： A61K35/12 ,  A61K38/20 ,  A61K38/13 ,  A61K31/573 ,  A61K31/4745 ,  A61K38/44 ,  A61K31/192

CPC分类号： A61F2/02 ,  A61F2/0077 ,  A61F2/07 ,  A61F2230/008 ,  A61F2250/0039 ,  A61F2250/0067

摘要： A medical device includes a carrier and an agent. The agent is formulated to control inflammation of biological tissue, such as heart tissue, and is releasably coupled to the carrier. The carrier is configured to be disposed in operative proximity to the biological tissue to be treated by the agent. In one embodiment, the carrier is configured to release the agent or otherwise deliver the agent to the biological tissue, thus controlling inflammation of the tissue. Also, a method to improve healing of biological tissue includes placing a medical device proximate to the heart of a patient, where the medical device has a carrier and an agent configured to control inflammation, the agent is releasably coupled to the carrier. In one embodiment, the method includes causing the agent to be released from the carrier.

摘要翻译： 医疗器械包括载体和药剂。 制剂用于控制诸如心脏组织的生物组织的炎症，并且可释放地联接到载体上。 载体被配置为设置在操作中接近要由药剂处理的生物组织。 在一个实施方案中，载体被配置为释放试剂或以其它方式将试剂递送到生物组织，从而控制组织的炎症。 此外，改善生物组织愈合的方法包括将医疗装置放置在靠近患者心脏的位置，其中医疗装置具有载体和被配置成控制炎症的药剂，药剂可释放地联接到载体上。 在一个实施例中，该方法包括使得试剂从载体释放。